logo-loader

Agenus Inc

Receive alerts
Market:
NASDAQ
Market Cap:
$357.01 m
Price
2.60 USD
Change
-1.52%
52 weeks high
3.86
52 weeks low
1.56

In brief

Agenus Inc., (Agenus), formerly Antigenics Inc., is a biotechnology company focused on the development and commercialization of technologies to treat cancers and infectious diseases, based on immunological approaches.